Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes. Kong D, Li G, Yang Z, Cheng S, et al. BMC Cancer 2022;22:84.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kong D, Li G, Yang Z, Cheng S, et al. Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes. BMC Cancer 2022;22:84.
PMID: 35057760